Research of Branchiooculofacial Syndrome has been linked to Branchio-oto-renal Syndrome, Cleft Lip, Branchial Clefts-congenital Disorder, Eye Abnormalities, Congenital Ocular Coloboma (disorder). The study of Branchiooculofacial Syndrome has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Branchiooculofacial Syndrome include Eye Development, Localization. These pathways complement our catalog of research reagents for the study of Branchiooculofacial Syndrome including antibodies and ELISA kits against TFAP2A, EYA1, LACRIMAL, SS18L1, BMP4.
Branchiooculofacial Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Branchiooculofacial Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 545 products for the study of Branchiooculofacial Syndrome that can be applied to Flow Cytometry, Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Branchiooculofacial Syndrome is also known as branchiooculofacial syndrome, hemangiomatous branchial clefts-lip pseudocleft syndrome, bof syndrome, branchial clefts with characteristic facies, growth retardation, imperforate nasolacrimal duct, and premature aging, branchial clefts with characteristic facies growth retardation imperforate nasolacrimal duct and premature aging, lip pseudocleft-hemangiomatous branchial cyst syndrome, lip pseudocleft-hemagiomatous branchial cyst syndrome, branchioma, bofs.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.